We argue that the long-term focus on HTA's technical inputs and related processes has failed because it implicitly endorses the state's framework. It misses the importance of making a philosophical case against a system whose primary flaw is that patients are servile to the state's economic interests.
Make the case against the state's imposition of economic interests as the only consideration
January 21, 2025 Latest NewsBioPharmaCommentNews of the DayLatest Video
New Stories
-
Immutep completes patient enrolment for EFTISARC-NEO Phase 2 trial
January 22, 2025 - - Australian Biotech -
Emyria announces key leadership changes
January 22, 2025 - - Latest News -
Island Pharmaceuticals says all subjects now enrolled in key arm PROTECT clinical trial
January 22, 2025 - - Australian Biotech -
LTR Pharma signs national pharmacy distribution agreement with Symbion
January 22, 2025 - - BioPharma -
Make the case against the state's imposition of economic interests as the only consideration
January 21, 2025 - - Latest News -
BioCina and NovaCina merger aims to bolster the global CDMO industry
January 21, 2025 - - Australian Biotech -
Australian company Vaxxas named stage winner of US prize to advance vaccine patches
January 20, 2025 - - Australian Biotech